Vertex Pharmaceuticals (Canada) Inc. et al. v. JAMP Pharma Corp.

Call to arrange a consultation

2026

T-2038-26

Pending

6(1) PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,733,908 (ivacaftor).

Counsel to:

JAMP Pharma Corporation

The decision is reported

Partner

Associate

Associate